03 Aug TomoTherapy extends reach to Germany
Madison, Wis. – TomoTherapy, Inc., producer of the Hi-Art radiation therapy device, is expanding its product reach to Germany.
The University Clinic Heidelberg will be the first of four major university hospitals to treat cancer patients with the Hi-Art System, a machine that combines on-board CT imaging with radiation therapy to destroy cancer cells with limited damage to healthy tissue.
Dr. Jürgen Debus, medical director of the clinic’s department of radio oncology and radiation therapy, said in a release that the system is a “perfect addition to our concept in Heidelberg,” which ranges from intensity moduated radiation therapy to heavy ion treatments.
Debus said that the improved precision of the technology allows the clinic to treat cases that have been very difficult to treat with standard linear accelerators.
Dr. Gabriele Sroka-Perez, head of medical physics for the department, said it was a challenge to install and commission the first unit in Germany because the technology required new approaches for the commissioning and approval process.
Additional German sites to receive the Hi-Art system include Charite Berlin, the University Clinic Essen, the Clinic of the Technical University Munich Rechts der Isar, and the University Clinic Hamburg.
“We are pleased to share this milestone with the University Clinic Heidelberg and with patients throughout the region,” said Dr. Fred Robertson, CEO of TomoTherapy.
• Cash-rich TomoTherapy has no plans for IPO
• City of Hope adds second TomoTherapy system
• Leading cancer institute to install three TomoTherapy systems
• Tech awards keynoter asks for support of UWM transformation
• TomoTherapy raises another $14M from existing investors